Europe Functional Genomics Market: Analysis and Forecast, 2023-2033

Europe Functional Genomics Market: Analysis and Forecast, 2023-2033


Introduction to Europe Functional Genomics Market In 2023, the Europe functional genomics market was valued at $3.01 billion, and it is expected to reach $10.69 billion by 2033, growing at a CAGR of 13.52% during the forecast period 2023-2033. The functional genomics market is poised for growth, primarily propelled by its expanding applications, particularly in the realms of targeted therapy and precision medicine.

Market Introduction

The functional genomics market in Europe is experiencing notable growth driven by advancements in genomic research and rising demand for personalized medicine. Functional genomics involves studying how genes interact with each other and the environment to understand biological functions. With Europe's strong presence in biotechnology and life sciences, coupled with significant investments in research and development, the region is witnessing a surge in genomic studies aimed at unraveling disease mechanisms and developing targeted therapies. Moreover, collaborations between academic institutions, biotech companies, and government agencies are fostering innovation and driving market expansion. Additionally, increasing adoption of high-throughput sequencing and gene editing technologies further propels the functional genomics market. As Europe continues to lead in genomic research, the functional genomics market is poised for continued growth, offering promising opportunities for advancements in healthcare and biotechnology.

Market Segmentation:

Segmentation 1: by Country

Germany
France
U.K.
Italy
Spain
Rest-of-Europe

How can this report add value to an organization?

Product/Innovation Strategy: The report considers functional genomics kits and assays-based companies. The industry is seeing constant development and product launches with new and innovative upgrades. Additionally, new discoveries of more efficient instruments and tools of functional genomics are increasing researchers' trust in functional genomics.

Growth/Marketing Strategy: The key components in Europe functional genomics are the kits and assays along with the instruments for sample analysis. The advancements in the overall functional genomics ecosystem are influencing the growth of this market.

Competitive Strategy: The key players in the Europe functional genomics market have been analyzed and profiled in the study, consisting of most product-based companies. Moreover, a detailed competitive benchmarking of the players operating in the Europe functional genomics market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.

Some prominent names established in this market are:

F. Hoffmann-La Roche Ltd
Merck KGaA
QIAGEN

*PDF email from publisher allows for 1-3 users, with permission to print*

Please Note:
It will take 1-5 business days to complete the report upon order confirmation.


Executive Summary
1 Markets
1.1 Product Definition
1.2 Inclusion and Exclusion Criteria
1.3 Market Scope
1.3.1 Scope of the Study
1.3.2 Key Questions Answered in the Report
1.4 Research Methodology
1.4.1 Functional Genomics Market: Research Methodology
1.4.2 Data Sources
1.4.3 Market Estimation Model
1.4.4 Criteria for Company Profiling
2 Market Overview
2.1 Functional Genomics Workflow Analysis
2.2 Future Potential
2.3 Impact of Functional Genomics
2.3.1 Gene Therapy
2.3.2 Drug Discovery and Development
2.3.3 Gene Expression
2.3.4 Single-Cell Analysis
3 Region
3.1 Overview
3.2 Europe
3.2.1 Germany
3.2.2 France
3.2.3 U.K.
3.2.4 Italy
3.2.5 Spain
3.2.6 Rest-of-Europe
4 Company Profiles
4.1 Overview
4.2 F. Hoffmann-La Roche Ltd
4.2.1 Company Overview
4.2.2 Role of F. Hoffmann-La Roche Ltd in the Functional Genomics Market
4.2.3 Financials
4.2.4 Key Insights about the Financial Health of the Company
4.2.5 Recent Developments
4.2.6 Analyst Perspective
4.3 Merck KGaA
4.3.1 Company Overview
4.3.2 Role of Merck KGaA in the Functional Genomics Market
4.3.3 Financials
4.3.4 Key Insights about the Financial Health of the Company
4.3.5 Analyst Perspective
4.4 QIAGEN
4.4.1 Company Overview
4.4.2 Role of QIAGEN in the Functional Genomics Market
4.4.3 Financials
4.4.4 Key Insights about the Financial Health of the Company
4.4.5 Recent Developments
4.4.6 Analyst Perspective
List of Figures
Figure 1: Europe Functional Genomics Market, $Billion, 2023 and 2033
Figure 2: Biological Features of Functional Genomics Approaches
Figure 3: Share of Functional Genomics Market (by Region), 2022
Figure 4: Functional Genomics Market: Research Methodology
Figure 5: Primary Research Methodology
Figure 6: Bottom-Up Approach (Segment-Wise Analysis)
Figure 7: Top-Down Approach (Segment-Wise Analysis)
Figure 8: Epigenomics Workflow
Figure 9: Transcriptomics Workflow
Figure 10: Proteomics Workflow
Figure 11: Metabolomics Workflow
Figure 12: Functional Genomics Market Snapshot (by Region)
Figure 13: Functional Genomics Market (by Region), $Billion, 2023-2033
Figure 14: Europe Functional Genomics Market, $Billion, 2022-2033
Figure 15: Europe Functional Genomics Market (by Country), $Billion, 2022-2033
Figure 16: Germany Functional Genomics Market, $Billion, 2022-2033
Figure 17: France Functional Genomics Market, $Billion, 2022-2033
Figure 18: U.K. Functional Genomics Market, $Billion, 2022-2033
Figure 19: Italy Functional Genomics Market, $Billion, 2022-2033
Figure 20: Spain Functional Genomics Market, $Billion, 2022-2033
Figure 21: Rest-of-Europe Functional Genomics Market, $Billion, 2022-2033
Figure 22: Functional Genomics Market, Total Number of Key Companies Profiled
Figure 23: F. Hoffmann-La Roche Ltd: Product Portfolio
Figure 24: F. Hoffmann-La Roche Ltd: Overall Financials, 2020-2022
Figure 25: F. Hoffmann-La Roche Ltd: Revenue (by Segment), 2020-2022
Figure 26: F. Hoffmann-La Roche Ltd: R&D Expenditure, 2020-2022
Figure 27: Merck KGaA: Product Portfolio
Figure 28: Merck KGaA: Overall Financials, $Million, 2020-2022
Figure 29: Merck KGaA: Revenue (by Segment), $Million, 2020-2022
Figure 30: Merck KGaA: Revenue (by Region), $Million, 2020-2022
Figure 31: Merck KGaA: R&D Expenditure, $Million, 2020-2022
Figure 32: QIAGEN.: Product Portfolio
Figure 33: QIAGEN: Overall Financials, $Million, 2019-2021
Figure 34: QIAGEN: Revenue (by Segment), $Million, 2019-2021
Figure 35: QIAGEN: Revenue (by Region), $Million, 2019-2021
Figure 36: QIAGEN N.V.: R&D Expenditure, $Million, 2019-2021
List of Tables
Table 1: Europe Functional Genomics Market: Impact Analysis
Table 2: Technological Trends in Functional Genomics Market
Table 3: Europe: Market Dynamics

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings